The editorial and publication processes of the Journal are conducted in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), and the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The Journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/apply/transparency/).
On submission of the manuscript, the authors are required to fill in the form and sign "Acknowledgement of Authorship, Conflict of Interest Statement, and Transfer of Copyright Agreement". Authors should clearly state whether or not any conflict of interest issue exists, and state their contribution to the study.
Manuscripts are scanned for plagiarism or duplication. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE). Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted, and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s). The journal uses plagiarism screening tool to screen all submissions and to verify the originality of content before publication.
Editor-in-chief has full authority over the entire editorial content of the journal and the timing of publication of that content. Journal owners do not interfere in the evaluation, selection, scheduling, or editing of individual articles either directly or by creating an environment that strongly influences decisions. Editors and reviewers make editorial decisions based on the validity of the work and its importance to the journal’s readers. Editors and reviewers are free to express critical but responsible views about all aspects of medicine.
All submitted material must be approved by the editorial board in order to be published. Articles will undergo a double-blind peer review, by at least two reviewers. Reviewers are selected among independent experts who are experienced authors who have publications in the international literature. Manuscripts are expected to be prepared in accordance with The Uniform Requirements for Manuscripts Submitted to Biomedical Journals - International Committee of Medical Journal Editors (http://www.icmje.org). Manuscripts focusing on three or fewer patients will be considered as a case report. Manuscripts should comply with the CARE statement (https://www.care-statement.org/checklist). For clinical case series that include four or more patients, we encourage authors to follow the Joanna Briggs Institute’s Checklist for Case Series (https://jbi.global/critical-appraisal-tools) for more complete and high-quality reporting.
After the review, the editorial board has the right to accept, ask for revision, or reject the manuscript. Once a manuscript is submitted, authors may not add, remove or change authors of the manuscript. If the revised version of the manuscript is not submitted within the allocated time (30 days) after the decision of revision, the revision option may be cancelled. Manuscripts may be rejected without peer review by the editor-in-chief if they do not comply with the instructions to authors or if they are beyond the scope of the Journal. Any manuscript that does not conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as reported at http://www.icmje.org/icmje-recommendations.pdf will also be rejected. Following rejection, details will be provided.
An approval of research protocols by the Ethics Committee in accordance with international agreements (Helsinki Declaration, revised 2013, Guide for the Care and Use of Laboratory Animals - https://www.nap.edu/catalog/5140.html) is required for experimental, clinical, and investigational drug studies, and some case reports.
All articles reporting human subjects must include a statement that the subjects gave informed patient consent to treatment and publication. Informed consent obtained from each patient and/or their legal representative should be presented with the following statement: "The patient and/or their legal representatives were informed that data from the case would be submitted for publication and gave their consent." In order not to violate patient privacy, authors must not reveal any identifying information without consent. It is the author's responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patient, signed releases of the patient or of their legal representative must be enclosed. Authors must archive the signed consent form and must be able to present it to the journal or ethics committee on request, which will be treated confidentially. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE).
The process for handling cases requiring corrections, retractions, and editorial expressions of concern
Corrections, Retractions & Expressions of Concern
To provide a better service to the researchers in the academic community, the Joint Diseases and Related Surgery Case Reportsbelieves that clarity in the publishing record is a must for information distribution. Recognizing a published article as a finalized “Version of Record” indicates that it is accurate, complete, and citable. The Joint Diseases and Related Surgery Case Reportsdefines this Version of Record as the initial article publication for open access journals.
It is assumed that manuscripts report on the work based on honest observations. However, occasionally information becomes available which may contradict this. In such cases, the Joint Diseases and Related Surgery Case Reports applies Committee on Publication Ethics (COPE) guidelines on corrections, retractions, and expressions of concern.
Corrections: Errors in published papers may be identified that requires publication of a correction in the form of a corrigendum or erratum. Since articles can be read and cited as soon as they are published, any changes thereafter could potentially impact those who read and cited the earlier version. The Joint Diseases and Related Surgery Case Reports provides authors an opportunity to review the article proofs prior to publication with the purpose of ensuring the accuracy of the content. Publishing an erratum or corrigendum increases the likelihood readers will find out about the change and also explains the specifics of the change.
Corrigenda and Errata will appear on a numbered page and contain the citation of the original article. If these corrections are insufficient to address an error, the Editor-in-Chief will handle them on a case-by-case basis. Inadequacies arising from the normal course of new scientific research are not within the scope of this and do not require any correction or withdrawal.
Expressions of Concern & Retractions: Where substantial doubt arises as to the honesty or integrity of a submitted or published article, it is the Editor-in-Chief's responsibility to ensure that the matter is adequately addressed, usually by the authors' sponsoring institution. In general, the Editor-in-Chief is not responsible for conducting the investigation or making a definite decision. The Editor-in-Chief should be promptly informed of the decision of the sponsoring institution and a retraction printed should it be determined that a fraudulent paper was published. Alternatively, the Editor-in-Chief may choose to publish an expression of concern over the aspects of the conduct or integrity of the work
During the whole publication process there will be a submission fee paid for online article submission, and an article processing charge required only if the article is accepted, effective from March 1st 2022.
The submission fee is 50 $ (for foreign authors) and 250 TL (for Turkish authors) per article. This fee is separate from the article processing charge (APC) and will be collected by the contracted IT Company (Yazılım Parkı) as usage fee for the online article submission and tracking system. The submission fee can be paid by credit card online as the last step of the manuscript submission within online article submission and tracking system. The submission fee can also be paid by wire transfer. In this case, your article will be processed after the payment is received. You can find the bank account information for the wire transfer below. This fee will not be repaid if the article is rejected in any stage. Neither our journal nor our foundation has any legal or financial liability due to these fees.
Yazılım Parkı Payment Information for Wire Transfer / EFT:
Bank Name: Garanti BBVA (Branch Name: Birlik Şubesi)
Swift Code (BIC Code): TGBATRISXXX
for $ IBAN: TR83 0006 2001 1820 0009 0925 96
for TL IBAN: TR84 0006 2001 1820 0006 2977 17
Payee's name: YAZILIMPARKI BİLİŞİM TEKNOLOJİLERİ DANIŞMANLIK OTOMASYON REK
Article Processing Charge
Joint Diseases and Related Surgery Case Reports is an immediate open access (gold open access) journal and all expenses and costs related to the journal are funded by article processing charges (APC). APC concerns only accepted articles for publication. APC is net 150 € (for foreign authors) or 1500 TL (for Turkish authors) (including all taxes) per article. Following acceptance for publication, this fee will be collected in advance before the publishing services. This amount will not be repaid even if the accepted article is afterwards withdrawn by the authors for any reason. These fees are in no way related to the scientific evaluations conducted voluntarily by our journal’s editorial board and consultant referees.
Ziraat Bankası Bilkent Plaza Ankara Subesi
for € IBAN: TR81 0001 0017 6289 9775 4450 06
Swift code: TCZBTR2A
for TL IBAN: TR38 0001 0017 6289 9775 4450 04
Payee’s name: Türkiye Eklem Hastalıkları Tedavi Vakfı İktisadi İşletmesi
Open Access policy
JDRS Case Reports is an immediate open access journal and full text of all published articles are freely available without embargo (Gold open access).
Turkish Joint Diseases Foundation has the international copyright of all the material published in the journal. The journal’s content is licensed under a Creative Commons Attribution-NonCommercial 4 International License (CC BY-NC 4.0). It allows users to read, download, copy, redistribute in any medium or format, print, search, or link to the full texts of the articles as well as to remix, transform, and build upon the material non-commercially, as long as appropriate credit is given.
Copyright and Licensing policy
Authors transfer the international copyright of all the material published in the journal to the Turkish Joint Diseases Foundation.
The journal’s content is licensed under a Creative Commons Attribution-NonCommercial 4 International License (CC BY-NC 4.0). It allows users to read, download, copy, redistribute in any medium or format, print, search, or link to the full texts of the articles as well as to remix, transform, and build upon the material non-commercially, as long as appropriate credit is given.
Data Sharing Policy
The journal encourages authors to share the data in the manuscript by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper. Shared data should be cited. If you have shared data, you need to describe how the data can be accessed) from the repository. The authors can use the proposals of The International Committee of Medical Journal Editors (ICMJE) for data sharing. (Taichman DB, Backus J, Baethge C, Bauchner H, de Leeuw PW, Drazen JM, et al. Sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors [Editorial]. Ann Intern Med. 2016;164:505-6. [PMID: 26792258] doi:10.7326/M15-2928)
Joint Diseases and Related Surgery Case Reports will not accept advertisements in any form.
Editor-in-Chief: Erdem Aras Sezgin, MD
Bahçesaray Mahallesi, Aksaray Üniversitesi Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, 68100, Merkez, Aksaray, TURKEY
Phone: +90 (382) 502 20 00
Publisher: Turkish Joint Diseases Foundation (Türkiye Eklem Hastalıkları Tedavi Vakfı)